A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2022-01-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT05076409
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
- First Posted Date
- 2021-10-05
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 13
- Registration Number
- NCT05068102
- Locations
- 🇳🇱
VU University Medical Center, Amsterdam, Netherlands
A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 81
- Registration Number
- NCT05065190
- Locations
- 🇨🇳
China-Japan Friendship Hospital, Beijing, China
🇨🇳The Second Hospital of Jilin University, Changchun, China
🇨🇳First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin
- Conditions
- First Posted Date
- 2021-09-21
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 39357
- Registration Number
- NCT05051904
- Locations
- 🇩🇪
Boehringer Ingelheim - International GmbH, Ingelheim am Rhein, Germany
Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1798
- Registration Number
- NCT05022784
- Locations
- 🇺🇸
Medicus Economics, LCC, Milton, Massachusetts, United States
A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 5
- Registration Number
- NCT05013385
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇨🇦Heritage Medical Research Clinic, Calgary, Alberta, Canada
🇸🇪Sahlgrenska Universitetssjukhuset, Mölndal, Mölndal, Sweden
A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 49
- Registration Number
- NCT04978493
- Locations
- 🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸Southern Star Research Institute, LLC, San Antonio, Texas, United States
🇺🇸University of Utah Health Sciences Center, Salt Lake City, Utah, United States
A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 83
- Registration Number
- NCT04978506
- Locations
- 🇩🇪
Charité - Universitätsmedizin Berlin, Berlin, Germany
A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
- Conditions
- Interventions
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 30
- Registration Number
- NCT04973163
- Locations
- 🇺🇸
Mary Crowley Cancer Research Center, Dallas, Texas, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇧🇪Edegem - UNIV UZ Antwerpen, Edegem/Antwerpen, Belgium
A Study in Healthy Men to Test How BI 474121 is Tolerated
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 32
- Registration Number
- NCT04964453
- Locations
- 🇯🇵
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku, Japan